These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 26507097

  • 1. Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Feng W, Jia YY, Zhang DY, Shi HR.
    Gynecol Endocrinol; 2016; 32(2):147-50. PubMed ID: 26507097
    [Abstract] [Full Text] [Related]

  • 2. Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
    Wu H, Ruan X, Jin J, Mueck AO.
    Gynecol Endocrinol; 2015 Jul; 31(7):548-51. PubMed ID: 26004979
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
    Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Martínez-Bermejo E, Lasunción MA, Escobar-Morreale HF.
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2453-61. PubMed ID: 17426085
    [Abstract] [Full Text] [Related]

  • 4. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
    Zhang S, Tu H, Yao J, Le J, Jiang Z, Tang Q, Zhang R, Huo P, Lei X.
    Reprod Biol Endocrinol; 2020 Jun 03; 18(1):58. PubMed ID: 32493421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 03; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L, Pasinetti E.
    Acta Obstet Gynecol Scand; 1995 Jan 03; 74(1):56-60. PubMed ID: 7856434
    [Abstract] [Full Text] [Related]

  • 10. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb 01; 118(2):209-13. PubMed ID: 15653205
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS, Al-Hilli AS, Hadi NR, Jamil DA, Al-Aubaidy HA.
    Diabetes Metab Syndr; 2016 Feb 01; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
    Jing Z, Liang-Zhi X, Tai-Xiang W, Ying T, Yu-Jian J.
    Gynecol Endocrinol; 2008 Oct 01; 24(10):590-600. PubMed ID: 19012104
    [Abstract] [Full Text] [Related]

  • 16. [Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
    Orbetsova M, Kamenov Z, Kolarov G, Zakharieva S, Khristov V, Atanasova I, Shigarminova R, Milcheva B, Genchev G.
    Akush Ginekol (Sofiia); 2006 Oct 01; 45(7):16-28. PubMed ID: 17489164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
    Cui N, Feng X, Zhao Z, Zhang J, Xu Y, Wang L, Hao G.
    Clin Ther; 2017 Apr 01; 39(4):751-758. PubMed ID: 28291580
    [Abstract] [Full Text] [Related]

  • 20. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA, Khurana ML, Nisar S, Shah PA, Shah ZA, Kulshrestha B, Gupta N, Zargar MA, Wani TA, Mudasir S, Mir FA, Taing S.
    J Clin Endocrinol Metab; 2013 Sep 01; 98(9):3599-607. PubMed ID: 23846820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.